Case Report January 13, 2022

Psychosis After SARS-CoV-2 in a Patient With Stable Schizophrenia and Allograft Kidney Transplant

; ; ; ; ; ;

Prim Care Companion CNS Disord 2022;24(1):21cr03132

  1. Barlati S, Nibbio G, Vita A. Schizophrenia during the COVID-19 pandemic. Curr Opin Psychiatry. 2021;34(3):203–210. PubMed CrossRef
  2. Toapanta N, Torres IB, Sellarés J, et al. Kidney transplantation and COVID-19 renal and patient prognosis. Clin Kidney J. 2021;14(suppl 1):i21–i29. PubMed CrossRef
  3. Baller EB, Hogan CS, Fusunyan MA, et al. Neurocovid: pharmacological recommendations for delirium associated with COVID-19. Psychosomatics. 2020;61(6):585–596. PubMed CrossRef
  4. Kozloff N, Mulsant BH, Stergiopoulos V, et al. The COVID-19 global pandemic: implications for people with schizophrenia and related disorders. Schizophr Bull. 2020;46(4):752–757. PubMed CrossRef
  5. Ferrando SJ, Klepacz L, Lynch S, et al. COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics. 2020;61(5):551–555. PubMed CrossRef
  6. Ponti G, Maccaferri M, Ruini C, et al. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57(6):389–399. PubMed CrossRef
  7. Egbert AR, Cankurtaran S, Karpiak S. Brain abnormalities in COVID-19 acute/subacute phase: a rapid systematic review. Brain Behav Immun. 2020;89:543–554. PubMed CrossRef
  8. Civan Kahve A, Kaya H, Darben Y, et al. From predictions to evidence: treatment compliance, disease progression and social compliance of patients with schizophrenia in the COVID-19 pandemic. Perspect Psychiatr Care. 2021;57(4):1991–1998. PubMed
  9. Abu Jawdeh BG. COVID-19 in kidney transplantation: outcomes, immunosuppression management, and operational challenges. Adv Chronic Kidney Dis. 2020;27(5):383–389. PubMed CrossRef
  10. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10(3):799–812. CrossRef
  11. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198. PubMed CrossRef
  12. Ali MAM, Spinler SA. COVID-19 and thrombosis: from bench to bedside. Trends Cardiovasc Med. 2021;31(3):143–160. PubMed CrossRef
  13. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615. PubMed CrossRef
  14. Huarcaya-Victoria J, Meneses-Saco A, Luna-Cuadros MA. Psychotic symptoms in COVID-19 infection: a case series from Lima, Peru. Psychiatry Res. 2020;293:113378. PubMed CrossRef
  15. Rentero D, Juanes A, Losada CP, et al. New-onset psychosis in COVID-19 pandemic: a case series in Madrid. Psychiatry Res. 2020;290:113097. PubMed CrossRef
  16. Smith CM, Komisar JR, Mourad A, et al. COVID-19–associated brief psychotic disorder. BMJ Case Rep. 2020;13(8):e236940. PubMed CrossRef
  17. Kozato N, Mishra M, Firdosi M. New-onset psychosis due to COVID-19. BMJ Case Rep. 2021;14(4):e242538. PubMed CrossRef
  18. Chacko M, Job A, Caston F 3rd, et al. COVID-19–induced psychosis and suicidal behavior: case report. SN Compr Clin Med. 2020;26:1–5. PubMed
  19. Ehrlich S, Geisler D, Yendiki A, et al. Associations of white matter integrity and cortical thickness in patients with schizophrenia and healthy controls. Schizophr Bull. 2014;40(3):665–674. PubMed CrossRef
  20. Mighdoll MI, Tao R, Kleinman JE, et al. Myelin, myelin-related disorders, and psychosis. Schizophr Res. 2015;161(1):85–93. PubMed CrossRef